Stonepine Capital Management »

AngioDynamics shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of AngioDynamics (ANGO) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in AngioDynamics

Tip: Access up to 7 years of quarterly data

All positions including AngioDynamics held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AngioDynamics by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $670k 60k 11.17
2025-06-30 $765k 77k 9.92

More positions owned by Stonepine Capital Management

Verastem Com New (VSTM)
Adma Biologics (ADMA)
Evolus (EOLS)
Zevra Therapeutics Com New (ZVRA)
Nektar Therapeutics Com New (NKTR)
Day One Biopharmaceuticals I (DAWN)
Xoma Royalty Corporation Com New (XOMA)
ACADIA Pharmaceuticals (ACAD)
Enanta Pharmaceuticals (ENTA)
X4 Pharmaceuticals Com New (XFOR)
Omniab (OABI)
Surrozen Com New (SRZN)
Tela Bio (TELA)
Indivior Ord (INDV)
Abeona Therapeutics Com New (ABEO)

View all positions for Stonepine Capital Management

Top funds holding AngioDynamics

Divisadero Street Capital Management
BlackRock
Systematic Financial Management
Point72 Asset Management
Vanguard Group
Millennium Management
Armistice Capital
Segall Bryant & Hamill
Bastion Asset Management
Dimensional Fund Advisors
UBS Group
Royce & Associates
Geode Capital Management
State Street Corporation
Renaissance Technologies

View all funds holding AngioDynamics